Close

Unusual 11 Mid-Day Movers 9/29: (ITCI) (ADHD) (MRNS) Higher; (CATB) (AEGR) (DRNA) Lower

September 29, 2016 12:55 PM EDT Send to a Friend
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) 63.1% LOWER; announced top-line results from the second Phase 3 clinical trial (Study ‘302) of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login